Other Clinical Trial - Preoperative Subclinical DVT NCT04502498

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Not yet recruiting

Preoperative subclinical DVT screening in locally advanced bladder cancer patients candidate for radical cystectomy.

60 patient with local advanced bladder cancer are subjected to preoperative lower limb duplex within 1 week preoperative to radical cystectomy

Recruitment information / eligibility
Status	Not yet recruiting
Enrollment	60
Est. completion date	October 1, 2021
Est. primary completion date	June 1, 2021
Accepts healthy volunteers	No
Gender	All
Age group	N/A and older
Eligibility	Inclusion Criteria: - any age - Any sex - Muscle invasive bladder cancer local advanced patients candidate for radical cystectomy Exclusion Criteria: - Unfit patients - any contraindication for surgery - obese - coagulopathy - bedridden

Diagnostic Test:
• Lower limb duplex & doppler
Lower limb duplex and doppler one week before radical cystectomy

Locations
Country	Name	City	State
n/a

Sponsors *(1)*
Lead Sponsor	Collaborator
Kasr El Aini Hospital

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	Preoperative subclinical DVT	Asymptomatic patients candidate for radical cystectomy	6 months